An Extended Access Program (EAP) for Perampanel

Status Available

Clinical Trial Summary

The main objective of this EAP is to ensure that participants participating in Study E2007-G000-332, Study E2007-G000-311, E2007-G000-238, E2007-G000-338 or EAP E2007-G000-401 continue to have access to perampanel until such time that the appropriate formulation of perampanel becomes commercially available in the country in which they reside or until no participants remain in the EAP.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Lennox Gastaut Syndrome
Primary Generalized Tonic-Clonic or Partial Onset Seizures
Seizures

Clinical Trial Details

NCT number	NCT02307578
Study type	Expanded Access
Source	Eisai Inc.
Contact	Eisai Medical Information
Phone	1-888-274-2378
Email	esi_medinfo@eisai.com
Status	Available
Phase

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02910297` - The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy
Recruiting	`NCT05339126` - RNS System LGS Feasibility Study	Phase 2
Active, not recruiting	`NCT03355209` - A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome	Phase 3
Completed	`NCT04062981` - Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome	Phase 1
Not yet recruiting	`NCT05066217` - EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children With Lennox Gastaut Syndrome	Phase 2
Recruiting	`NCT04611438` - Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome	Phase 3
Completed	`NCT05364021` - Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies	Phase 1/Phase 2
Terminated	`NCT03955432` - Long-term Cardiac Monitoring in Epilepsy	N/A
Completed	`NCT02224560` - Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults	Phase 3
Not yet recruiting	`NCT05485831` - Epidyolex® in Lennox Gastaut and Dravet Syndrome: an Observational Study in ITALY
Recruiting	`NCT05044819` - Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution	Phase 4
Not yet recruiting	`NCT05374824` - Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
Active, not recruiting	`NCT02655198` - Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy	Phase 2
Completed	`NCT03467113` - A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol	Phase 1
Completed	`NCT03731715` - Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome	Phase 1
Recruiting	`NCT05219617` - Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults	Phase 3
Active, not recruiting	`NCT03936777` - A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome	Phase 3
Available	`NCT03778424` - An Extended Access Program (EAP) for Participants Who Have Completed Rufinamide Study E2080-G000-303
Available	`NCT06149663` - Intermediate-Size Expanded Access Protocol (EAP) for LP352